Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | GRK2 | P25098 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL173771 | 0.81 | BBOX1 (0.36) | BBOX1 | |
| SCHEMBL28344485 | 0.80 | BBOX1 (0.49) | BBOX1LMNAMEN1POLBGRK2 | |
| SCHEMBL21408834 | 0.79 | BBOX1 (0.64) | BBOX1LMNAMEN1POLBGRK2 | |
| SCHEMBL19734903 | 0.77 | BBOX1 (0.58) | BBOX1LMNAMEN1POLBGRK2 | |
| SCHEMBL26789436 | 0.76 | BBOX1 (0.73) | BBOX1LMNAMEN1POLBGRK2 | |
| SCHEMBL25663649 | 0.76 | BBOX1 (0.73) | BBOX1LMNAMEN1POLBGRK2 | |
| SCHEMBL22345119 | 0.76 | BBOX1 (0.56) | BBOX1LMNAMEN1POLBGRK2 | |
| SCHEMBL25459605 | 0.75 | BBOX1 (0.54) | BBOX1LMNAMEN1POLBGRK2 | |
| SCHEMBL15547776 | 0.75 | BBOX1 (0.64) | BBOX1LMNAMEN1POLBGRK2 | |
| SCHEMBL15380499 | 0.75 | BBOX1 (0.64) | BBOX1LMNAMEN1POLBGRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114539345-B | High-flux protein sample pretreatment method based on pore plate | 中国科学院大连化学物理研究所 | 2023-12-15 | — | — | CN | claimed |
| CN-114539345-A | High-flux protein sample pretreatment method based on pore plate | 中国科学院大连化学物理研究所 | 2022-05-27 | — | — | CN | claimed |
| WO-2005039381-A2 | COMPOSITIONS AND PROCESSES FOR ANALYSIS OF PHARMACOLOGIC AGENTS IN BIOLOGICAL SAMPLES | DRUG RISK SOLUTIONS, L.L.C. (US) | 2005-05-06 | — | — | WO | claimed |
| US-20050037386-A1 | Composition and processes for analysis of pharmacologic agents in biological samples | DRUG RISK SOLUTIONS, L.L.C. | 2005-02-17 | — | — | US | claimed |
| EP-0433225-B1 | Process for the production of biologically active protein (e.g. TGF) | NOVARTIS AG (CH) | 1999-04-07 | — | — | EP | claimed |
| EP-0444240-B1 | A method for classifying leukocytes and a reagent used therefor | TOA MEDICAL ELECTRONICS (JP) | 1996-06-26 | — | — | EP | claimed |
| US-5389549-A | Method for classifying leukocytes and a reagent used therefor | TOA MEDICAL ELECTRONICS CO., LTD. (JP) | 1995-02-14 | — | — | US | claimed |
| US-20240207488-A1 | METHODS FOR MAKING ACELLULAR TISSUE MATRICES | LIFECELL CORPORATION (US) | 2024-06-27 | — | — | US | disclosed |
| WO-2024057291-A1 | SYSTEMS FOR MAKING A FAT-INCLUSIVE SKIN GRAFT TREATMENT COMPOSITION, FAT-INCLUSIVE SKIN GRAFT TREATMENT COMPOSITION, AND METHODS OF MAKING SAME | KERECIS HF (IS) | 2024-03-21 | — | — | WO | disclosed |
| CN-112469792-B | Patterned surface with suction | BVW控股公司 | 2024-02-27 | — | — | CN | disclosed |
| EP-4313185-A1 | A COLORED BIOLOGIC WOUND TREATMENT PROVIDING HEALING PROGRESS MONITORING | Kerecis HF (IS) | 2024-02-07 | — | — | EP | disclosed |
| EP-4313187-A1 | WOUND TREATMENTS AND METHODS OF STABILIZING, PROTECTING, AND TREATING A WOUND | Kerecis HF (IS) | 2024-02-07 | — | — | EP | disclosed |
| CN-116917458-A | Modular, configurable bioreactor system for a production line | 德卡产品有限公司 | 2023-10-20 | — | — | CN | disclosed |
| EP-0564786-A2 | Method for processing and preserving collagen-based tissues for transplantation | LIFECELL CORPORATION (US) | 1993-10-13 | — | — | EP | disclosed |
| US-5215896-A | Pendant polypeptide with amphiphilic helical structure | CREATIVE BIOMOLECULES, INC. (US) | 1993-06-01 | — | — | US | disclosed |
| US-5192507-A | Immobilization and detection of narcotics | ARTHUR D. LITTLE, INC. (US) | 1993-03-09 | — | — | US | disclosed |
| EP-0503297-A1 | GLIA activating factor and its production | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1992-09-16 | — | — | EP | disclosed |
| US-5124358-A | Nematocides | THE BOARD OF REAGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) | 1992-06-23 | — | — | US | disclosed |
| WO-1991010427-A2 | THE EFFECT OF TRANSGLUTAMINASE INHIBITION ON MICROFILARIAE DEVELOPMENT AND MACROFILARIAE VIABILITY | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1991-07-25 | — | — | WO | disclosed |
| US-5011910-A | Heptapeptides having fluorogenic and quenching groups as substrates for protease; colorimetric analysis, efficiency | WASHINGTON UNIVERSITY (US) | 1991-04-30 | — | — | US | disclosed |